Cover Image

TREM2‐Mediated Cholesterol Efflux in Macrophages Inhibits Anti‐Tumor Immunity via Limitation of CD4 + T and NK Cells (Adv. Sci. 5/2026)

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yunhan Wang, Weina Yu, Xinxin Wang, Qitai Zhao, Qingyang Lei, Aitian Li, Shasha Liu, Tian Wang, Li Yang, Yi Zhang
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Advanced Science
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TREM2‐Mediated Cholesterol Efflux in Macrophages Inhibits Anti‐Tumor Immunity via Limitation of CD4 + T and NK Cells
by: Yunhan Wang, et al.
Published: (2025)

NK Cells Promote Macrophage Foam Cell Formation via TIGIT / CD155 ‐Mediated Cholesterol Metabolism
by: Jing Li, et al.
Published: (2026)

Tumor Cell‐Derived CXCL2 Potentiates Neutrophil‐Mediated Antitumor Immunity by Inhibiting Cholesterol Biosynthesis in Hepatocellular Carcinoma
by: Xin Liu, et al.
Published: (2025)

Cryoablation Activates the cGAS–STING‐CXCL10 Axis in Macrophages to Enhance Anti‐Tumor Immunity in NSCLC
by: Xinxin Zhi, et al.
Published: (2026)

Pro‐Atherosclerotic Effects of Osteopontin Is Contributed to Promoting Foam Cell Formation Derived From VSMCs by Inhibiting Cholesterol Efflux
by: Wentao Liu, et al.
Published: (2025)

ABCA6 Regulates Chondrogenesis and Inhibits Joint Degeneration via Orchestrated Cholesterol Efflux and Cellular Senescence
by: Yi Wang, et al.
Published: (2025)

Targeting piRNA‐137463 Inhibits Tumor Progression and Boosts Sensitivity to Immune Checkpoint Blockade via De Novo Cholesterol Biosynthesis in Lung Adenocarcinoma
by: Yuning Zhan, et al.
Published: (2024)

USP18 Promotes Cholesterol Efflux and Mitigates Atherosclerosis by Deubiquitinating ABCG1
by: Yang An, et al.
Published: (2025)

Leveraging Macrophage Metabolic Reprogramming for Enhanced Anti‐Tumor Immunity
by: Zhiyun Liu, et al.
Published: (2026)

Targeted Deletion of Peroxiredoxin 1 Enhances Anti‐Tumor Immunity in Colorectal Cancer by Reprogramming the Immunosuppressive Tumor‐Associated Macrophages
by: Yuqi Sun, et al.
Published: (2025)

Lysosomal Membrane‐Biomimetic Metal‐Organic Framework Potentiates Autophagy/Epigenetic‐Mediated Anti‐Tumor Immunity
by: Yiqiao Wang, et al.
Published: (2024)

Targeting WTAP/ROR1/WNT5A‐Mediated Crosstalk Between Glioma Stem Cells and Macrophages to Normalize Tumor Vasculature and Enhance Chemotherapy (Adv. Sci. 21/2026)
by: Xiaoyong Chen, et al.
Published: (2026)

DADA Enhances CD8 + T Cell Stemness to Improve Anti‐Tumor Immunity and Immunotherapy Efficacy
by: Mingyue Bi, et al.
Published: (2026)

NNMT Orchestrates Metabolic‐Epigenetic Reprogramming to Drive Macrophage‐Myofibroblast Transition in Hypertrophic Scarring (Adv. Sci. 11/2026)
by: Xiwen Dong, et al.
Published: (2026)

TOPK Inhibition Promotes Anti‐Tumor Immunity Via eIF4F Complex Mediated STAT1 Translation in Gastric Cancer
by: Junbing Chen, et al.
Published: (2025)

SLC2A3‐Mediated Lactate Metabolism Promotes Lung Cancer Bone Metastasis by Modulating P53 Lactylation and Immune Evasion (Adv. Sci. 22/2026)
by: Yi Ding, et al.
Published: (2026)

CDK4/6 Inhibition Induces CD8 + T Cell Antitumor Immunity via MIF‐Induced Functional Orchestration of Tumor‐Associated Macrophages
by: Lin He, et al.
Published: (2025)

Forsythoside B and Its Derivatives as Novel ASGR1 Inhibitors for Enhanced Cholesterol Efflux
by: Manru Ma, et al.
Published: (2025)

Targeted Inhibition of Tumor Extracellular Vesicle Secretion Improving the Anti‐Tumor Immunity of Lymph Node‐Targeted Vaccines
by: Fei Wang, et al.
Published: (2025)

Adhesion‐Related Macrophages Regulate Metabolic Homeostasis Through CAV‐1 Dependency (Adv. Sci. 26/2026)
by: Wanyu Hu, et al.
Published: (2026)

Substantially Altered Local and Systemic Immunity in Ischemia‐Free Versus Conventional Liver Transplantation (Adv. Sci. 23/2026)
by: Tao Luo, et al.
Published: (2026)

Targeting DAP5 Disrupts Alternate Mode of Translational Initiation in Tregs and Potentiates Antitumor Immunity (Adv. Sci. 10/2026)
by: Xiaojiang Lai, et al.
Published: (2026)

Hybrid Ginseng‐derived Extracellular Vesicles‐Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis (Adv. Sci. 17/2024)
by: Haoran Wang, et al.
Published: (2024)

Cryo‐Shocked Tumor‐Reprogrammed Sonosensitive Antigen‐Presenting Cells Improving Sonoimmunotherapy via T Cells and NK Cells Immunity
by: Xindi Qian, et al.
Published: (2025)

Tumor‐Derived CDC37 Inhibits Antigen Cross‐Presentation in Dendritic Cells and Impairs Anti‐Tumor Immunity in Breast Cancer
by: Ruxin Wang, et al.
Published: (2025)

TSHR‐Targeting Nucleic Acid Aptamer Treats Graves' Ophthalmopathy via Novel Allosteric Inhibition (Adv. Sci. 4/2026)
by: Yanchen Zhang, et al.
Published: (2026)

Reprogramming Antitumor Immunity: NK Cell Strategies to Navigate the Immunosuppressive Tumor Microenvironment
by: Tereza Kochs, et al.
Published: (2026)

Dual Aptamers‐Based SETDB1 PROTACs as Effective Anti‐Tumor Strategies for Breast Cancer (Adv. Sci. 18/2026)
by: Yanxuan Guo, et al.
Published: (2026)

Nanosponge for Iron Chelation and Efflux: A Ferroptosis‐Inhibiting Approach for Myocardial Infarction Therapy
by: Qingbo Lv, et al.
Published: (2024)

Nano‐Biohybrid‐Induced Inflammatory Cancer Cell Death Reprograms Anti‐Tumor Immunity to Suppress Tumor Progression and Metastasis
by: Yunlong Li, et al.
Published: (2026)

MARCO+ Tumor‐Associated Macrophages Impede CD8+ T Cell Immunity to Facilitate Immunotherapy Resistance in Renal Cell Carcinoma
by: Jiayuan Chen, et al.
Published: (2025)

An mRNA Tumor Nanovaccine Expressing Tumor Antigen Fused With Angiotensin II Facilitates Type 1 Conventional Dendritic Cell‐Mediated Anti‐Tumor Immunity
by: Chunyuan Xie, et al.
Published: (2026)

Versatile DNA Hydrogel‐Mediated Delivery of Ginsenoside‐Encapsulated Small Extracellular Vesicles to Boost Diabetic Wound Repair (Adv. Sci. 25/2026)
by: Jianming Xing, et al.
Published: (2026)

ACT001 Suppresses the Malignant Progression of Small‐Cell Lung Cancer by Inhibiting Lactate Production and Promoting Anti‐Tumor Immunity
by: Xiao‐Jing Ding, et al.
Published: (2025)

The Polarization of Macrophages Regulated by KCNG3 via the Activation of ASK1 Mediated by Potassium Ion Efflux
by: Shuting Zhang, et al.
Published: (2025)

PGK1 Suppresses CD8 + T Cell‐Mediated Antitumor Immunity Through CCL2/CCR2/Tumor‐Associated Macrophages Axis in Hepatocellular Carcinoma
by: Xi Liu, et al.
Published: (2026)

Wogonin Attenuates Atherosclerosis via KLF11‐Mediated Suppression of PPARα‐YAP1‐Driven Glycolysis and Enhancement of ABCA1/G1‐Mediated Cholesterol Efflux
by: Chuanrui Ma, et al.
Published: (2025)

CD20 + FCRL4 + B Cells Activate CD8 + T Cells via MHC‐I Restriction in Nasopharyngeal Carcinoma Anti‐Tumor Immunity
by: Benjian Zhang, et al.
Published: (2026)

Novel Arf1 Inhibitors Drive Cancer Stem Cell Aging and Potentiate Anti‐Tumor Immunity
by: Yuetong Wang, et al.
Published: (2024)

Elotuzumab Enhances CD16‐Independent NK Cell‐Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell‐Enhancing Genes
by: Yan-Hua Wang, et al.
Published: (2024)